Roche recalls new eye therapy Susvimo on leakage fears, aims for market return ‘within a year or so’
Just as doctors were starting to cozy up to Roche and Genentech’s new eye drug delivery therapy, the companies are pulling the product from U.S. shelves.
Roche ha...
Continue Reading →
